Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.

Margaux LafaurieGuillaume Martin-BlondelPierre DelobelNassim KamarSandrine CharpentierAgnès SommetGuillaume Moulisnull null

Published in: BMC pharmacology & toxicology (2021)

Overall, this study provide some evidences for an absence of an increased risk of unfavorable outcome with previous exposure to corticosteroids in the general setting of patients hospitalized for COVID-19.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported